Modulation of Human Recombinant GABA A Receptors by Pregnanediols
- 1 January 1996
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 35 (9-10), 1223-1231
- https://doi.org/10.1016/s0028-3908(96)00066-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interaction of positive allosteric modulators with human and Drosophila recombinant GABA receptors expressed in Xenopus laevis oocytesBritish Journal of Pharmacology, 1996
- Neurosteroid modulation of native and recombinant GABAA receptorsCellular and Molecular Neurobiology, 1996
- Neurosteroids and GABAA receptor functionTrends in Pharmacological Sciences, 1995
- GABAA/Benzodiazepine receptor heterogeneity: Neurophysiological implicationsNeuropharmacology, 1995
- Cloning and functional expression of a Drosophila gamma-aminobutyric acid receptor.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Multiple benzodiazepine receptors: no reason for anxietyTrends in Pharmacological Sciences, 1992
- Neurosteroids: Endogenous bimodal modulators of the GABAA receptor mechanism of action and physiological significanceProgress in Neurobiology, 1992
- Novel anxiolytics that act as partial agonists at benzodiazepine receptorsTrends in Pharmacological Sciences, 1990
- Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complexNeuroscience & Biobehavioral Reviews, 1990
- 5α-pregnan-3α,20α-diol behaves like a partial agonist in the modulation of GABA-stimulated chlride ion uptake by synaptoneurosomesEuropean Journal of Pharmacology, 1989